









Markets
/
Stocks
/
nasdaq-albt
/

Avalon Globocare Corp

ALBT

2.690USD

-0.030-1.10%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

6.32MMarket Cap

LossP/E TTM



Avalon Globocare Corp

2.690

-0.030-1.10%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively weak. Its valuation is considered fairly valued,and institutional recognition is very high. The company shows very weak stock market performance, in line with its fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

150 / 207

Overall Ranking

490 / 4720

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. The Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.

Growing

The company is in a growing phase, with the latest annual income totaling USD 1.33M.

Overvalued

The company’s latest PE is -0.22, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 494.33K shares, increasing 14.69% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 1.58K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.97.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 5.39, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 350.41K, representing a year-over-year increase of 6.87%, while its net profit experienced a year-over-year increase of 531.26%.

Score

Industry at a Glance

Previous score

5.39

Change



Financials

3.86

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.93

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.57

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.46

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.11

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -0.23, which is 9.88% below the recent high of -0.25 and -286.54% above the recent low of -0.87.

Score

Industry at a Glance

Previous score

2.80

Change

1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 150/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

There is no earnings forecast score for this company; the Healthcare Equipment & Supplies industry's average is 7.70.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 3.26, which is lower than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 3.09 and the support level at 2.16, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

3.26

Change

-0.02

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(3)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.099

Buy

RSI(14)

59.871

Neutral

STOCH(KDJ)(9,3,3)

66.885

Neutral

ATR(14)

0.201

High Vlolatility

CCI(14)

62.576

Neutral

Williams %R

22.472

Buy

TRIX(12,20)

0.885

Sell

StochRSI(14)

47.961

Buy

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

2.664

Buy

MA10

2.619

Buy

MA20

2.371

Buy

MA50

2.329

Buy

MA100

2.842

Sell

MA200

3.628

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 14.25%, representing a quarter-over-quarter decrease of 41.08%. The largest institutional shareholder is The Vanguard, holding a total of 1.58K shares, representing 0.04% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Lu (Wenzhao)

238.93K

+0.00%

Jin (David)

103.00K

Vision Capital NY, Inc.

100.00K

Li (Meng)

34.33K

+0.00%

Equitable Holdings, Inc.

14.22K

UBS Financial Services, Inc.

2.56K

-54.92%

Tauzin (Wilbert J II)

1.04K

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.01, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.02. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.